Cite
Leptomeningeal Disease in Breast Cancer: Pre-Treatment Prognostic Factors and Outcomes.
MLA
Milligan, M. G., et al. “Leptomeningeal Disease in Breast Cancer: Pre-Treatment Prognostic Factors and Outcomes.” International Journal of Radiation Oncology, Biology, Physics, vol. 111, no. 3, Nov. 2021, pp. e574–75. EBSCOhost, https://doi.org/10.1016/j.ijrobp.2021.07.1548.
APA
Milligan, M. G., Aitelli, A., Mehan, W. A., Shi, D. D., Cagney, D. N., Oh, K. S., Wang, N., Brastianos, P., Moy, B., Lin, N. U., & Shih, H. A. (2021). Leptomeningeal Disease in Breast Cancer: Pre-Treatment Prognostic Factors and Outcomes. International Journal of Radiation Oncology, Biology, Physics, 111(3), e574–e575. https://doi.org/10.1016/j.ijrobp.2021.07.1548
Chicago
Milligan, M.G., A. Aitelli, W.A. Mehan, D.D. Shi, D.N. Cagney, K.S. Oh, N. Wang, et al. 2021. “Leptomeningeal Disease in Breast Cancer: Pre-Treatment Prognostic Factors and Outcomes.” International Journal of Radiation Oncology, Biology, Physics 111 (3): e574–75. doi:10.1016/j.ijrobp.2021.07.1548.